Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Structure (London, England : 1993)|June 30, 2000
Conformations of the rhodopsin third cytoplasmic loop grafted onto bacteriorhodopsinJ B Heymann, M Pfeiffer, V Hildebrandt, et al.
International Journal of Language & Communication Disorders|May 9, 2001
The public awareness of aphasia: an international surveyC Code, N S Mackie, E Armstrong, et al.
The Pharmacogenomics Journal|July 12, 2017
Genome-wide association studies of placebo and duloxetine response in major depressive disorderM Maciukiewicz, V S Marshe, A K Tiwari, et al.
Acta Psychiatrica Scandinavica|November 28, 2001
Familial occurrence of tardive dyskinesiaD J Müller, T G Schulze, M Knapp, et al.
American Journal of Medical Genetics|July 18, 2000
Association study of the tryptophan hydroxylase gene and bipolar affective disorder using family-based internal controlsM Rietschel, A Schorr, M Albus, et al.
Neuroscience Letters|July 25, 2000
Decreased frontal lobe ratio of N-acetyl aspartate to choline in familial schizophrenia: a proton magnetic resonance spectroscopy studyW Block, T A Bayer, R Tepest, et al.
Clinical Pharmacology and Therapeutics|May 23, 2013
Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosingS G Leckband, J R Kelsoe, H M Dunnenberger, et al.
The Pharmacogenomics Journal|January 27, 2011
Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesiaA K Tiwari, C C Zai, O Likhodi, et al.
Clinical Pharmacology and Therapeutics|March 15, 2013
Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressantsJ K Hicks, J J Swen, C F Thorn, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|March 14, 2001
Affective symptomatology in schizophrenia: a risk factor for tardive dyskinesia?T G Schulze, D J Müller, H Krauss, et al.
Pageof 12